BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND FLI1, SIC-1, 2313, ENSG00000151702, Q01543, EWSR2 AND Treatment
20 results:

  • 1. treatment-related adverse events of immune checkpoint inhibitors combined with angiogenesis inhibitors in advanced lung cancer: A systematic review and meta-analysis.
    Zheng Y; Dong H; Yu Y; Hu Z; Xue C; Zhang X; Cui H
    Int Immunopharmacol; 2023 Oct; 123():110785. PubMed ID: 37598630
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer.
    Sun J; Sun Y; Miniderima ; Wang X
    Pathol Oncol Res; 2023; 29():1610710. PubMed ID: 37342361
    [No Abstract]    [Full Text] [Related]  

  • 3. Rh-endostatin plus camrelizumab and chemotherapy in first-line treatment of advanced non-small cell lung cancer: A multicenter retrospective study.
    Pu X; Wang Q; Liu L; Chen B; Li K; Zhou Y; Sheng Z; Liu P; Tang Y; Xu L; Li J; Kong Y; Xu F; Xu Y; Wu L
    Cancer Med; 2023 Apr; 12(7):7724-7733. PubMed ID: 36494905
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Transcription factor Fli-1 as a new target for antitumor drug development.
    Li L; Yu J; Cheng S; Peng Z; Luo H
    Int J Biol Macromol; 2022 Jun; 209(Pt A):1155-1168. PubMed ID: 35447268
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeted siRNA nanocarrier: a platform technology for cancer treatment.
    Bäumer N; Tiemann J; Scheller A; Meyer T; Wittmann L; Suburu MEG; Greune L; Peipp M; Kellmann N; Gumnior A; Brand C; Hartmann W; Rossig C; Müller-Tidow C; Neri D; Strassert CA; Rüter C; Dersch P; Lenz G; Koeffler HP; Berdel WE; Bäumer S
    Oncogene; 2022 Apr; 41(15):2210-2224. PubMed ID: 35220407
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A YAP1::TFE3 cutaneous low-grade fibromyxoid neoplasm: A novel entity!
    Patton A; Bridge JA; Liebner D; Chung C; Iwenofu OH
    Genes Chromosomes Cancer; 2022 Apr; 61(4):194-199. PubMed ID: 34874592
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinicopathologic, immunohistochemical, molecular cytogenetic profile with treatment and outcomes of 34 cases of Ewing sarcoma with epithelial differentiation, including 6 cases with "Adamantinoma-like" features, diagnosed at a single institution, India.
    Rekhi B; Shetty O; Vora T; Gulia A; Bajpai J; Laskar S
    Ann Diagn Pathol; 2020 Dec; 49():151625. PubMed ID: 32932018
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ETS Proteins Bind with Glucocorticoid Receptors: Relevance for treatment of Ewing Sarcoma.
    Srivastava S; Nataraj NB; Sekar A; Ghosh S; Bornstein C; Drago-Garcia D; Roth L; Romaniello D; Marrocco I; David E; Gilad Y; Lauriola M; Rotkopf R; Kimchi A; Haga Y; Tsutsumi Y; Mirabeau O; Surdez D; Zinovyev A; Delattre O; Kovar H; Amit I; Yarden Y
    Cell Rep; 2019 Oct; 29(1):104-117.e4. PubMed ID: 31577941
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Solitary pulmonary capillary hemangioma: Clinicopathologic and radiologic characteristics of nine surgically resected cases.
    Zhao J; Shao J; Zhu L; Yu K; Zhao R; Ding W; Zhang J; Han Y
    Pathol Res Pract; 2018 Nov; 214(11):1885-1891. PubMed ID: 30268596
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. IMP3 as a prognostic biomarker in patients with malignant peritoneal mesothelioma.
    Hui S; Guo-Qi Z; Xiao-Zhong G; Chun-Rong L; Yu-Fei L; Dong-Liang Y
    Hum Pathol; 2018 Nov; 81():138-147. PubMed ID: 30031101
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell lung cancer Treated with Chemotherapy and Bevacizumab.
    Bonanno L; De Paoli A; Zulato E; Esposito G; Calabrese F; Favaretto A; Santo A; Conte AD; Chilosi M; Oniga F; Sozzi G; Moro M; Ciccarese F; Nardo G; Bertorelle R; Candiotto C; De Salvo GL; Amadori A; Conte P; Indraccolo S
    Clin Cancer Res; 2017 Jul; 23(13):3316-3324. PubMed ID: 28119362
    [No Abstract]    [Full Text] [Related]  

  • 12. Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial.
    Chung V; Mansfield AS; Braiteh F; Richards D; Durivage H; Ungerleider RS; Johnson F; Kovach JS
    Clin Cancer Res; 2017 Jul; 23(13):3277-3284. PubMed ID: 28039265
    [No Abstract]    [Full Text] [Related]  

  • 13. Langerhans cell sarcoma: an unusual microscopic presentation.
    Gagnon AL; Daniel S; Greer K; Patterson JW; Tchernev G; Chokoeva AA; Wollina U; Lotti T; Fioranelli M; Roccia MG; Guarneri C; Aguilera N
    J Biol Regul Homeost Agents; 2016; 30(2 Suppl 2):39-43. PubMed ID: 27373133
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Primary Ewing sarcoma of vulva, confirmed with molecular cytogenetic analysis: A rare case report with diagnostic and treatment implications.
    Rekhi B; Chinnaswamy G; Vora T; Shah S; Rangarajan V
    Indian J Pathol Microbiol; 2015; 58(3):341-4. PubMed ID: 26275259
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pulmonary epithelioid hemangioendothelioma presenting with vertebral metastases: a case report.
    Sardaro A; Bardoscia L; Petruzzelli MF; Nikolaou A; Detti B; Angelelli G
    J Med Case Rep; 2014 Jun; 8():201. PubMed ID: 24942542
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Aberrant expression of neuroendocrine markers in angiosarcoma: a potential diagnostic pitfall.
    Tessier Cloutier B; Costa FD; Tazelaar HD; Folpe AL
    Hum Pathol; 2014 Aug; 45(8):1618-24. PubMed ID: 24846674
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PNET with neuroendocrine differentiation of the lung: Report of an unusual entity.
    Barroca H; Souto Moura C; Lopes JM; Lisboa S; Teixeira MR; Damasceno M; Bastos P; Sobrinho-Simões M
    Int J Surg Pathol; 2014 Aug; 22(5):427-33. PubMed ID: 24141023
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Transcriptional regulatory networks in human lung adenocarcinoma.
    Meng X; Lu P; Bai H; Xiao P; Fan Q
    Mol Med Rep; 2012 Nov; 6(5):961-6. PubMed ID: 22895549
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Primitive neuroectodermal tumor/Ewing's sarcoma of the urinary bladder: a case report and its molecular diagnosis.
    Okada Y; Kamata S; Akashi T; Kurata M; Nakamura T; Kihara K
    Int J Clin Oncol; 2011 Aug; 16(4):435-8. PubMed ID: 21063743
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases.
    Jimenez RE; Folpe AL; Lapham RL; Ro JY; O'Shea PA; Weiss SW; Amin MB
    Am J Surg Pathol; 2002 Mar; 26(3):320-7. PubMed ID: 11859203
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.